These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 10595504)

  • 1. Assessment of animal models for MS and demyelinating disease in the design of rational therapy.
    Steinman L
    Neuron; 1999 Nov; 24(3):511-4. PubMed ID: 10595504
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs of abuse and experimental autoimmune diseases.
    Lyman WD
    Adv Exp Med Biol; 1991; 288():81-92. PubMed ID: 1659140
    [No Abstract]   [Full Text] [Related]  

  • 3. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.
    Raine CS
    Lab Invest; 1984 Jun; 50(6):608-35. PubMed ID: 6202955
    [No Abstract]   [Full Text] [Related]  

  • 4. Growth factor treatment of demyelinating disease: at last, a leap into the light.
    Ransohoff RM; Howe CL; Rodriguez M
    Trends Immunol; 2002 Nov; 23(11):512-6. PubMed ID: 12401395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis.
    Aminian A; Noorbakhsh F; Ghazi-Khansari M; Kafami L; Javadi S; Hassanzadeh G; Rahimian R; Dehpour AR; Mehr SE
    Neuroscience; 2013 Sep; 248():299-306. PubMed ID: 23774631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune aspects of demyelinating diseases.
    Swanborg RH
    Immunol Ser; 1990; 52():155-67. PubMed ID: 2091778
    [No Abstract]   [Full Text] [Related]  

  • 7. [Demyelination and autoimmunity].
    Lebar R
    Pathol Biol (Paris); 1987 Mar; 35(3):275-83. PubMed ID: 3295694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acamprosate modulates experimental autoimmune encephalomyelitis.
    Sternberg Z; Cesario A; Rittenhouse-Olson K; Sobel RA; Leung YK; Pankewycz O; Zhu B; Whitcomb T; Sternberg DS; Munschauer FE
    Inflammopharmacology; 2012 Feb; 20(1):39-48. PubMed ID: 22090150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Th1 and Th2 cells in autoimmune demyelinating disease.
    Nagelkerken L
    Braz J Med Biol Res; 1998 Jan; 31(1):55-60. PubMed ID: 9686179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine experimental autoimmune encephalomyelitis: a model of immune-mediated inflammation and multiple sclerosis.
    Glabinski AR; Tani M; Tuohy VK; Ransohoff RM
    Methods Enzymol; 1997; 288():182-90. PubMed ID: 9356995
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced myelination in autoimmunity and in normal development induced by glatiramer acetate.
    Aharoni R; Arnon R
    Isr Med Assoc J; 2014 Oct; 16(10):611-3. PubMed ID: 25438444
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis.
    Turner MJ; Pang PT; Chretien N; Havari E; LaMorte MJ; Oliver J; Pande N; Masterjohn E; Carter K; Reczek D; Brondyk W; Roberts BL; Kaplan JM; Siders WM
    J Neuroimmunol; 2015 Aug; 285():4-12. PubMed ID: 26198912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenesis of multiple sclerosis and other neural autoimmune diseases].
    Lassmann H
    Verh Dtsch Ges Pathol; 1996; 80():109-15. PubMed ID: 9064993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid Kruppel-like factor 2 deficiency exacerbates neurological dysfunction and neuroinflammation in a murine model of multiple sclerosis.
    Shi H; Sheng B; Zhang C; Nayak L; Lin Z; Jain MK; Atkins GB
    J Neuroimmunol; 2014 Sep; 274(1-2):234-9. PubMed ID: 25052583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrocutaneous xanthoma disseminatum and disseminated demyelinating encephalomyelitis.
    Pfeiffer G; Hagel C; Eckert B; Zschaber R; Gross G; Bamberger CM
    Eur Neurol; 2000; 44(2):123-4. PubMed ID: 10965168
    [No Abstract]   [Full Text] [Related]  

  • 16. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.
    Fuller KG; Olson JK; Howard LM; Croxford JL; Miller SD
    Methods Mol Med; 2004; 102():339-61. PubMed ID: 15286394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating event.
    Horakova D; Zivadinov R; Weinstock-Guttman B; Havrdova E; Tamaño-Blanco M; Tyblova M; Hussein S; Bergsland N; Willis L; Krasensky J; Vaneckova M; Seidl Z; Lelkova P; Ramanathan M
    J Neuroimmunol; 2011 Jul; 236(1-2):76-80. PubMed ID: 21621859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Iranian herbal-marine medicine, MS14, ameliorates experimental allergic encephalomyelitis.
    Tafreshi AP; Ahmadi A; Ghaffarpur M; Mostafavi H; Rezaeizadeh H; Minaie B; Faghihzadeh S; Naseri M
    Phytother Res; 2008 Aug; 22(8):1083-6. PubMed ID: 18570265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The nature of the demyelinating process in clinical and experimental neurology].
    Markov DA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(7):967-75. PubMed ID: 5368925
    [No Abstract]   [Full Text] [Related]  

  • 20. Oligodendrocytes: the putative target cells of multiple sclerosis.
    Abramsky O
    Isr J Med Sci; 1982 Jan; 18(1):149-58. PubMed ID: 7040297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.